Document Detail


The barriers to adequate pain management with opioid analgesics.
MedLine Citation:
PMID:  8097339     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Despite widespread knowledge about many aspects of pain relief and the availability of appropriate opioid analgesics, inadequate pain management of cancer patients remains pervasive. The reasons can be classified into three categories: (1) societal barriers: (some health care providers still classify patients requiring "atypical" pain control as actual or potential drug abusers and continue to be affected by the deep-rooted negative image of opium and its misuse throughout history), (2) knowledge deficits (care givers often do not recognize the need for individualized treatment in accordance with the specific pain syndrome, the profile of the patient, the appropriate analgesic regimen, or the route of dosing; in addition, physical dependence, addiction, and tolerance are often regarded as synonymous and not clearly distinguished from one another), and (3) influence of governmental regulations (because drug regulatory guidelines concerning opioids are often vague and ambiguous, physicians are uncertain about what constitutes legitimate opioid use and fear regulatory and legal sanctions when prescribing opioid analgesics in higher than "normal" amounts; as a result, pain is often undertreated). It is imperative that we strive to overcome these barriers and correct societal biases and misinformation in order to create a more rational plan for effective cancer pain management in which opioid analgesics are utilized appropriately.
Authors:
C S Hill
Related Documents :
19523029 - Predictors of resolution of aberrant drug behavior in chronic pain patients treated in ...
19300039 - Improvement in sensory pain rating after palliative systemic radionuclide therapy in pa...
10739359 - Factors influencing the opioid response in advanced cancer patients with pain followed ...
20960989 - Analgesic update: tapentadol hydrochloride.
12516889 - Cellular mechanisms of opioid tolerance and the clinical approach to the opioid toleran...
20307799 - Pain and continued opioid use in individuals receiving buprenorphine-naloxone for opioi...
24731899 - Mindfulness-based cognitive therapy for the treatment of headache pain: a mixed-methods...
23958279 - Beta-adrenergic receptor mechanisms and pain sensitivity in women with menstrually rela...
24392649 - Medical decision-making inspired from aerospace multisensor data fusion concepts.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Seminars in oncology     Volume:  20     ISSN:  0093-7754     ISO Abbreviation:  Semin. Oncol.     Publication Date:  1993 Apr 
Date Detail:
Created Date:  1993-05-18     Completed Date:  1993-05-18     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0420432     Medline TA:  Semin Oncol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1-5     Citation Subset:  IM    
Affiliation:
Department of Neuro-Oncology, University of Texas System Cancer Center, M.D. Anderson Hospital and Tumor Institute, Houston.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Analgesics, Opioid / adverse effects,  therapeutic use*
Drug and Narcotic Control
Humans
Neoplasms / physiopathology*
Pain / drug therapy*,  etiology
United States
Chemical
Reg. No./Substance:
0/Analgesics, Opioid

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages.
Next Document:  Lithocholic acid-sensitive mutant cells isolated from Chinese hamster ovary cells are cross-sensitiv...